Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent

K-Number: K162208 · 2017-01-09

Decision Date2017-01-09
Product CodeCFN
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent is a medical device manufactured by Beckman Coulter, Inc.. It received FDA 510(k) clearance on 2017-01-09 under approval number K162208. The device is classified under product code CFN. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent?

DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent is a medical device that received FDA 510(k) clearance on 2017-01-09. It is manufactured by Beckman Coulter, Inc.. The 510(k) number is K162208.

When was DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent approved by the FDA?

DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent received FDA 510(k) clearance on 2017-01-09, under approval number K162208.

What company makes DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent?

DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent is manufactured by Beckman Coulter, Inc..

What is the FDA product code for DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent?

The FDA product code for DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent is CFN.

Related Clinical Trials

Other Devices by Beckman Coulter, Inc.

View all 77 devices →

Related Devices (Code: CFN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.